e-learning
resources
ERJ
2010
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cystic fibrosis neutrophils have normal intrinsic reactive oxygen species generation
McKeon D. J., Cadwallader K. A., Idris S., Cowburn A. S., Pasteur M. C., Barker H., Haworth C. S., Bilton D., Chilvers E. R., Condliffe A. M.
Source:
Eur Respir J 2010; 35: 1264-1272
Journal Issue:
June
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
McKeon D. J., Cadwallader K. A., Idris S., Cowburn A. S., Pasteur M. C., Barker H., Haworth C. S., Bilton D., Chilvers E. R., Condliffe A. M.. Cystic fibrosis neutrophils have normal intrinsic reactive oxygen species generation. Eur Respir J 2010; 35: 1264-1272
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
Cystic fibrosis transmembrane conductance regulator pharmacotherapy
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=88
Year: 2006
Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator (CFTR) ion transport
Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science
Year: 2013
LATE-BREAKING ABSTRACT: Reducing inflammation in the lung by targeting the endothelial cystic fibrosis transmembrane conductance regulator with copper-tobramycin
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014
Aspergillus
-induced superoxide production by cystic fibrosis phagocytes is associated with disease severity
Source: ERJ Open Res, 4 (2) 00068-2017; 10.1183/23120541.00068-2017
Year: 2018
Cross-talk of inflammatory mediators and airway epithelium reveals the cystic fibrosis transmembrane conductance regulator as a major target
Source: ERJ Open Res, 7 (4) 00247-2021; 10.1183/23120541.00247-2021
Year: 2021
Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence
Source: Eur Respir J 2001; 17: 27-35
Year: 2001
Atypical cystic fibrosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=38
Year: 2006
Activation of membrane nadph oxidase in idiopathic pulmonary fibrosis (IPF) fibroblasts
Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair
Year: 2007
α1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients
Source: Eur Respir J 2007; 29: 240-250
Year: 2007
NADPH oxidase 4 deficiency protects from bleomycin-induced epithelial cell death and pulmonary fibrosis
Source: Annual Congress 2010 - New insights into reactive oxygen species
Year: 2010
Endothelial dysfunction in cystic fibrosis: imbalance NOS/arginase?
Source: Annual Congress 2007 - Cystic fibrosis lung disease: from diagnosis to end-stage
Year: 2007
Neutrophilic inflammation predisposes to structural lung disease in cystic fibrosis (CF) via neutrophil elastase activity
Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies
Year: 2009
Targeting cystic fibrosis inflammation in the age of CFTR modulators: focus on macrophages
Source: Eur Respir J, 57 (6) 2003502; 10.1183/13993003.03502-2020
Year: 2021
Decreased expression of haem oxygenase-1 by alveolar macrophages in idiopathic pulmonary fibrosis
Source: Eur Respir J 2008; 31: 1030-1036
Year: 2008
The chemokine decoy PA401 decreases interleukin-8 and chemotactic activity of cystic fibrosis airway samples
Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science
Year: 2013
Expression and function of cystic fibrosis transmembrane conductance regulator in rat intrapulmonary arteries
Source: Eur Respir J 2007; 30: 857-864
Year: 2007
Channelopathies in bronchiectasis
Source: Eur Respir Mon 2011; 52: 150-162
Year: 2011
Oxidation contributes to low glutathione in the airways of children with cystic fibrosis
Source: Eur Respir J 2014; 44: 122-129
Year: 2014
Expression of HCLCA1 in cystic fibrosis lungs is associated with mucus overproduction
Source: Eur Respir J 2004; 23: 846-850
Year: 2004
Characterization of cystic fibrosis airway epithelium
in vitro
Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept